Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient aged between 30 to 65 years 2. Patient having symptoms of Madhumeha 3. Patient with diagnosed cases of DM-II 4. Patient with FBS in range of 126mg/dl to 250mg/dl and PPBS in range of 200mg/dl to 350 mg/dl or both and HbA1c less than 10% 5. Patient consuming oral-hypoglycemic agents for a duration more than 1 year and having poor glycemic control 6. Patient with chronicity less than 5 years 7. Patient with willingness to participate in the study and provide informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women 2. Patient with type 1 diabetes 3. Patient with FBS more than 250mg/dl PPBS more than 350 mg/dl 4. Patients with Madhumeha upadrava or asadhya laxana 5. Patients with DM 2 on insulin therapy and Drug induced diabetes mellitus 6. Patients with hepatic impairment. 7. Uncontrolled hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the change in FBS/PPBS levels from baseline to the end of the treatment period.Timepoint: Baseline to the end of the treatment period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will include changes subjective parameters, HbA1c, liver function tests, renal function tests, and incidence of adverse eventsTimepoint: Baseline, 45th day ,end of the treatment period. HbA1c-Baseline to the end of the treatment period. | — |
Countries
India
Contacts
National Institute of Ayurveda, Deemed to be university, Jaipur